Trials (Fondazione I.R.C.C.S. Policlinico San Matteo): Revision history

From Beacon

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

6 December 2025

4 December 2025

2 December 2025

4 December 2023

  • curprev 18:3718:37, 4 December 2023‎ Francine talk contribs‎ 180,645 bytes +180,645‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Fondazione I.R.C.C.S. Policlinico San Matteo page '''NCTID''': NCT05210790 '''Title''': A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera '''Study Summary''': The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV. '''Sponsor''': Protagonist Therapeutics, Inc. '''..."
Retrieved from "https://wiki.beaconcancer.org/index.php?title=Trials_(Fondazione_I.R.C.C.S._Policlinico_San_Matteo)"
Powered by MediaWiki
Powered by Semantic MediaWiki